Equifax is starting to look like an interesting contrarian setup.
Technically, the stock is now testing a major long-term support zone around the $150–160 area. This level has acted as an important pivot several times since 2020, and price is now back into that zone after a sharp decline from the 2024–2025 highs.
This is not a confirmed reversal yet.
EFX is still trading below its 200-week moving average, currently around $227, and the short-term trend remains under pressure. A clean reclaim of the $170–180 area would be the first sign that buyers are stepping back in.
The bigger confirmation would come only if the stock can reclaim the $220–230 zone, where the 200-week moving average and previous resistance are sitting.
Until then, this is a support-zone setup, not a bullish breakout.
But the risk/reward is starting to look interesting.
The fundamental backdrop is not broken. Equifax delivered record Q1 2026 revenue of $1.65 billion, up 14% year-over-year, while adjusted EPS rose 22% to $1.86. Growth was supported by mortgage recovery, Workforce Solutions, and continued demand for credit and verification services.
The key point:
The stock is falling, but the business is still growing.
That difference matters.
EFX is tied to several cyclical pressures: mortgage activity, interest rates, credit demand, employment verification, and consumer lending. If rates stay higher for longer and mortgage volumes remain weak, the market may continue to pressure the multiple.
But if the rate cycle improves and mortgage activity recovers, Equifax could benefit from operating leverage in a business that already has strong data assets and recurring demand.
My view:
EFX is not a buy because the chart is bullish.
The chart is still damaged.
EFX is interesting because the market is pushing the stock into a major long-term support zone while the company continues to report growth.
The key level for me is $170–180.
Below that, it is still a falling knife.
Above that, the market may start treating this less like a breakdown and more like a recovery setup.
The bigger confirmation would come above $220–230.
This is where contrarian trades usually begin:
not when the chart looks perfect,
but when price reaches a major support zone while fundamentals remain intact.
Technically, the stock is now testing a major long-term support zone around the $150–160 area. This level has acted as an important pivot several times since 2020, and price is now back into that zone after a sharp decline from the 2024–2025 highs.
This is not a confirmed reversal yet.
EFX is still trading below its 200-week moving average, currently around $227, and the short-term trend remains under pressure. A clean reclaim of the $170–180 area would be the first sign that buyers are stepping back in.
The bigger confirmation would come only if the stock can reclaim the $220–230 zone, where the 200-week moving average and previous resistance are sitting.
Until then, this is a support-zone setup, not a bullish breakout.
But the risk/reward is starting to look interesting.
The fundamental backdrop is not broken. Equifax delivered record Q1 2026 revenue of $1.65 billion, up 14% year-over-year, while adjusted EPS rose 22% to $1.86. Growth was supported by mortgage recovery, Workforce Solutions, and continued demand for credit and verification services.
The key point:
The stock is falling, but the business is still growing.
That difference matters.
EFX is tied to several cyclical pressures: mortgage activity, interest rates, credit demand, employment verification, and consumer lending. If rates stay higher for longer and mortgage volumes remain weak, the market may continue to pressure the multiple.
But if the rate cycle improves and mortgage activity recovers, Equifax could benefit from operating leverage in a business that already has strong data assets and recurring demand.
My view:
EFX is not a buy because the chart is bullish.
The chart is still damaged.
EFX is interesting because the market is pushing the stock into a major long-term support zone while the company continues to report growth.
The key level for me is $170–180.
Below that, it is still a falling knife.
Above that, the market may start treating this less like a breakdown and more like a recovery setup.
The bigger confirmation would come above $220–230.
This is where contrarian trades usually begin:
not when the chart looks perfect,
but when price reaches a major support zone while fundamentals remain intact.
منشورات ذات صلة
إخلاء المسؤولية
لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.
منشورات ذات صلة
إخلاء المسؤولية
لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.